Adição na publicação
#15.35
10/19/2021
RPI 2650
Application data
Number
112019021411Type
Filing
Publication
PCT
EP2018059237 The application was abandoned: examination was not requested within the 36 months following the 04/11/2018 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/19/2021. We update with every new RPI gazette, published weekly.
Applicants
F. HOFFMANN-LA ROCHE AG
CH
Inventors
C. K. (pessoa física)
CH
P. U. (pessoa física)
CH
V. N. (pessoa física)
CH
IPC Classification
Priority claims
EP
17166436.0 · 04/13/2017
Abstract
A invenção provê métodos e composições para o tratamento do câncer, o método compreende a administração de um imunoconjugado de IL-2, um agonista de CD40 e, opcionalmente, um antagonista de ligação do eixo PD-1.
Publications in the Brazilian Industrial Property Gazette (RPI).
#15.35
10/19/2021
RPI 2650
#11.1.1
10/05/2021
RPI 2648
#11.1
07/20/2021
RPI 2637
#1.3
05/05/2020
RPI 2574
#1.1
10/22/2019
RPI 2546
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.